16325-1-AP

antibody from Proteintech Group

Targeting: CXCL2 CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, SCYB2

ELISA (Data presented on provider website)

Antibody Data

Product number

16325-1-AP

Provider

Proteintech Group

Product name

CXCL2 antibody

Antibody type

Polyclonal

Description

CXCL2 antibody (Cat. #16325-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Gene Signature-Based Drug Screening Reveals Ponatinib Enhances Immunotherapy Efficacy in Triple-Negative Breast Cancer by Reversing MDSC-Mediated Immunosuppressive Tumor Microenvironment.

Wang Q, Li S, Wu Y, Yu X, Dai Y, Wang Y, Li L, Yang M, Lin K, Shao W, Wang H, Wang H, Zhang G, Wang D
Research (Washington, D.C.) 2025;8:0915

---

A Novel Self-Regulated, Non-Directional Magnetic Thermos-Brachytherapy (125)I Seed Enhances Anticancer Efficacy by Rescuing Immune Escape.

Xu B, Wu YM, Cheng YF, Dong L, Ding SW, Chen SR, Chen BD, Yang RP, Zhang WH, Wang YJ, Mao WP, Shi F, Jin ZC, Chen JJ, Qiao EQ, Wang YQ, Li JZ, Zeng P, Wu CW, Zhang W, Xie JB, Lu J, Teng GJ
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Nov;12(43):e08091

---

Integrated analysis identifies CD276 in fibroblasts as a malignancy predictor and regulator of neutrophil infiltration in hepatoblastoma.

Ding M, Zhu G, Chen T, Zhu J, Mao S, Tang X, Wu H, Zhen N, Sun F, Pan Q, Ma J
Hepatology communications 2025 Nov 1;9(11)

---

Targeting Deltex E3 Ubiquitin Ligase 2 Inhibits Tumor-associated Neutrophils and Sensitizes Hepatocellular Carcinoma Cells to Immunotherapy.

Wu X, Chen J, Chen Y, Song S, Fang Y, Mao S, Gao J, Zhu G, Qu W, Zhao Q, Yang R, Guan Z, Chu T, Bu Y, Wang Y, Chen F, Zhou J, Fan J, Tang Z, Liu W, Ruan Y, Shi Y
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Feb;12(7):e2408233

---

Langhans giant cells regulate cutaneous immune responses during mycobacterial infection through CXCL1/CXCL2 secretion.

Jiang Y, Jiang H, Zou Y, Wang Z, Gan T, Zeng R, Shi Y, Zhang W, Wang H
International immunopharmacology 2025 Apr 16;152:114447

---

Molecular dynamics of chemotactic signalling orchestrates dental pulp stem cell fibrosis during aging.

Sun T, Zhong Q, Yu X, Luo H, Ren F, Liu C, Chen P, Flores-Borja F, Sun H, An Z
Frontiers in cell and developmental biology 2024;12:1530644

---

GL13K-modified titanium regulates osteogenic differentiation via the NF-κB pathway.

Han Y, Xing X, Zhou L, Huang S, Lin Z, Hong G, Chen J
International immunopharmacology 2024 Jan 5;126:111279

---

Magnesium isoglycyrrhizinate ameliorates lipopolysaccharide-induced liver injury by upregulating autophagy and inhibiting inflammation via IL-22 expression.

Zhou X, Li X, Yi K, Liang C, Geng S, Zhu J, Xie C, Zhong C
Bioorganic chemistry 2022 Nov;128:106034

---

Correlations of AKIP1, CXCL1 and CXCL2 expressions with clinicopathological features and survival profiles in cervical cancer patients.

Wan X, Hong Z, Mao Y, Di W
Translational cancer research 2020 Feb;9(2):726-734